Disparities for Risk of Recurrent Hemorrhagic Stroke Unexplained

Share this content:
Disparities for Risk of Recurrent Hemorrhagic Stroke Unexplained
Disparities for Risk of Recurrent Hemorrhagic Stroke Unexplained

WEDNESDAY, June 6, 2018 (HealthDay News) -- Black and Hispanic patients are at higher risk for stroke recurrence than white patients, according to a study published online June 6 in Neurology.

Axana Rodriguez-Torres, M.P.H., from the University of California Irvine, and colleagues assessed whether recurrence risk for intracerebral hemorrhage (ICH) is higher among black and Hispanic individuals and whether this disparity is attributable to differences in blood pressure (BP) measurements. Data came from a longitudinal study conducted at Massachusetts General Hospital (759 participants), as well as the Ethnic/Racial Variations of Intracerebral Hemorrhage study (1,532 participants).

The researchers found that of the survivors (1,121 white, 529 black, and 605 Hispanic), both black and Hispanic patients displayed higher systolic BP (SBP) during follow-up (P < 0.05). Greater SBP variability during follow-up was also seen among black participants (P = 0.032). Black and Hispanic patients were at higher ICH recurrence risk (P < 0.05), which remained higher after adjusting for BP measurements and their variability (hazard ratio for Hispanic patients, 1.51 [P = 0.004]; hazard ratio for black patients, 1.98 [P < 0.001]).

"The differences in blood pressure among these groups do not fully account for the differences in the risk of having another stroke," a coauthor said in a statement. "More research is needed to determine the factors behind this disparity."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Incident Contrast Sensitivity Common in Middle-Aged Adults

Incident Contrast Sensitivity Common in Middle-Aged Adults

Factors linked to elevated risk include cadmium level in highest quintile, older age, more plaque sites

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Reduces all-cause mortality, cardiovascular-related hospitalizations compared with placebo

Scribes Improve Physician Workflow, Patient Interaction

Scribes Improve Physician Workflow, Patient Interaction

Scribes lower EHR documentation burden for doctors and increase time spent interacting with patients

is free, fast, and customized just for you!




Already a member?

Sign In Now »